Delivery Order 75N92019D00017-75N92021F00001
Award Date
9/8/21
Potential Completion Date
6/30/24
Potential Value
$1.6M
Federal Agency
National Heart Lung and Blood Institute
Ultimate Awardee
Lovelace Biomedical Research Institute
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Albuquerque, NM 87108, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Lovelace Biomedical Research Institute, a not-for-profit preclinical contract research organization. The $234,478 contract is for the Gene Therapy Resource Program (GTRP) Pharmacology and Toxicology Core Laboratory. It is a cost-plus-fixed-fee contract with a period of performance through June 30, 2024. Lovelace Biomedical Research Institute...
This federal contract award was issued by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to the Lovelace Biomedical Research Institute. The $1,143,792.16 cost-plus-fixed-fee contract is for the GENE THERAPY RESOURCE PROGRAM (GTRP) and calls for the awardee to provide a Pharmacology and Toxicology Core Laboratory. The contract does not have a set-aside designation. Lovelace Biomedical Research Institute is a not-for-profit...
This federal contract award, valued at $868,802.65, was issued by the National Heart Lung and Blood Institute (NHLBI) to Lovelace Biomedical Research Institute, a not-for-profit preclinical contract research organization. The contract supports the NHLBI's Gene Therapy Resource Program (GTRP) by providing resources and services from three core laboratories: a Pharmacology and Toxicology Core Laboratory, a Preclinical Vector Core Laboratory, and a Clinical Coordinating Center. This contract is not...
This is a cost-plus-fixed-fee delivery order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Lovelace Biomedical Research Institute, a not-for-profit preclinical contract research organization. The $625,343.90 contract is for the PHARMACOLOGY/TOXICOLOGY CORE LABORATORY PROJECT under the Gene Therapy Resource Program (GTRP). Lovelace will provide a range of preclinical research services to support the...
This federal contract award was issued by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI), a subsidiary of Lovelace Biomedical Research Institute. The $203,807.96 contract is a delivery order for Task Area A under the Pharmacology-Toxicology Core Lab task order 7 of the NHLBI's Gene Therapy Resource Program (GTRP). The work, which has no set-aside designation,...
This is a cost-plus-fixed-fee task order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Heart Lung and Blood Institute to Lovelace Biomedical Research Institute, a not-for-profit contract research organization. The $352,485.43 task order is for pharmacology/toxicology core laboratory services in support of the Gene Therapy Research Program (GTRP). It does not have a set-aside designation. Lovelace Biomedical has a history of serving as a...
This is a delivery order under the Gene Therapy Resource Program (GTRP) contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH). The GTRP contract provides pharmacology and toxicology core laboratory services to support gene therapy research and development. The $10,766 delivery order was awarded to Lovelace Biomedical Research Institute, a not-for-profit preclinical contract research organization. Lovelace will provide...
This is a federal contract award from the National Heart Lung and Blood Institute (NHLBI), a civilian agency under the Department of Health and Human Services, to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI) for the "Gene Therapy Resource Program (GTRP), Pharmacology-Toxicology Core Lab." The contract is a $1,748,740.00 cost-plus-fixed-fee delivery order with a period of performance through July 31, 2017. LBERI, a non-profit organization doing business as...
This is a federal contract award issued by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI), a subsidiary of Lovelace Biomedical Research Institute. The $1,013,722.26 award is for Task Order 6, Task Area B under the GTRP Pharmacology-Toxicology Core Lab contract. The work will be performed in Albuquerque, NM and the period of performance runs through April 15,...
This federal contract award, valued at $3,632,884.00, was issued by the National Center for Advancing Translational Sciences (NCATS), a civilian agency, to the Lovelace Biomedical Research Institute, a not-for-profit preclinical contract research organization. The contract is for the efficacy and safety evaluation of a lead gene therapy candidate in propionic acidemia (PA) disease mouse models, as well as the development of bioanalytical assay methods. The period of performance is from September...